This inventor holds 2 USPTO granted patents. Top assignee: Rutgers, The State University of New Jersey. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Emine E Abali: Innovator in Cancer Research
Introduction
Emine E Abali is a prominent inventor based in Tenafly, NJ (US). She has made significant contributions to the field of cancer research, particularly in the area of hormone-refractory prostate cancer. With a total of two patents to her name, her work is paving the way for innovative treatment methods.
Latest Patents
Abali's latest patents focus on E2F as a target for hormone-refractory prostate cancer. The inventions provide amino acid sequences that compete with E2F for DNA binding. Additionally, methods for using these amino acid sequences for the treatment of hormone-refractory prostate cancer are also included in her patents.
Career Highlights
Emine E Abali is affiliated with Rutgers, the State University of New Jersey. Her research and inventions have garnered attention in the scientific community, showcasing her dedication to advancing cancer treatment.
Collaborations
Some of her notable coworkers include Joseph R Bertino and Debabrata Banerjee. Their collaborative efforts contribute to the innovative research being conducted at Rutgers.
Conclusion
Emine E Abali's work in cancer research exemplifies the impact of innovation in medicine. Her patents and collaborations highlight her commitment to finding effective treatments for challenging medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile